Fresenius Kabi recalls one lot of Morphine Sulfate Injection after labeling error mixes Dilaudid syringes

Fresenius Kabi announced a voluntary recall of a single lot of its Morphine Sulfate Injection USP, Simplist 2 mg/1 mL product.

The recall stems from a labeling mistake where the MicroVault container marked as Morphine 2 mg/1 mL may actually hold a prefilled syringe of Dilaudid (hydromorphone) 0.5 mg/0.5 mL.

Because the mix‑up could cause severe respiratory depression or death, especially in opioid‑naïve patients, those with respiratory disease, children, or patients taking CNS depressants are at greatest risk.

No adverse event reports have been received for the affected lot, and the company is recalling the product at the user level to prevent any harm.